List of Certificates of Suitability (CEPs) for cep_2023_266___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Question

Looking for Certificates of Suitability (CEPs) for CEP 2023-266 - Rev 01 of Hubei Gedian Humanwell Pharmaceutical Co., Ltd. Ezhou City Cn

score 20 · Accepted Answer

Hubei Gedian Humanwell Pharmaceutical Co., Ltd. Ezhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Hubei Gedian Humanwell focuses on R&D, production, & sales of fertility regulation drugs & steroidal APIs.

One of their significant offerings is Oxcarbazepine, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-266 - Rev 01

This Chemical Type CEP, issued on January 26, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2577 associated with this CEP further emphasizes

List of Certificates of Suitability (CEPs) for cep_2023_266___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Hubei Gedian Humanwell Pharmaceutical

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

DIGITAL CONTENT

3 CORPORATE CONTENT #SupplierSpotlight

3 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

FINISHED DOSAGE FORMULATIONS

KEY PRODUCTS

EXCIPIENTS

INSPECTIONS & REGISTRATIONS

Filters

CEP 2023-266 - Rev 01

Valid

Chemical

2024-01-26

2577

01

Looking for Certificates of Suitability (CEPs) for CEP 2023-266 - Rev 01 of Hubei Gedian Humanwell Pharmaceutical Co., Ltd. Ezhou City Cn